These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 8706033)
21. Methylation tolerance in mismatch repair proficient cells with low MSH2 protein level. Claij N; Te Riele H Oncogene; 2002 Apr; 21(18):2873-9. PubMed ID: 11973647 [TBL] [Abstract][Full Text] [Related]
22. DNA mismatch repair proteins promote apoptosis and suppress tumorigenesis in response to UVB irradiation: an in vivo study. Young LC; Thulien KJ; Campbell MR; Tron VA; Andrew SE Carcinogenesis; 2004 Oct; 25(10):1821-7. PubMed ID: 15166087 [TBL] [Abstract][Full Text] [Related]
23. The frequency of Muir-Torre syndrome among Lynch syndrome families. South CD; Hampel H; Comeras I; Westman JA; Frankel WL; de la Chapelle A J Natl Cancer Inst; 2008 Feb; 100(4):277-81. PubMed ID: 18270343 [TBL] [Abstract][Full Text] [Related]
24. The Muir-Torre syndrome: a rare variant of hereditary nonpolyposis colorectal cancer associated with hMSH2 mutation. Suspiro A; Fidalgo P; Cravo M; Albuquerque C; Ramalho E; Leitão CN; Costa Mira F Am J Gastroenterol; 1998 Sep; 93(9):1572-4. PubMed ID: 9732950 [TBL] [Abstract][Full Text] [Related]
25. Spontaneous and mutagen-induced loss of DNA mismatch repair in Msh2-heterozygous mammalian cells. Borgdorff V; van Hees-Stuivenberg S; Meijers CM; de Wind N Mutat Res; 2005 Jul; 574(1-2):50-7. PubMed ID: 15914206 [TBL] [Abstract][Full Text] [Related]
26. Ischemia-induced K-ras mutations in human colorectal cancer cells: role of microenvironmental regulation of MSH2 expression. Shahrzad S; Quayle L; Stone C; Plumb C; Shirasawa S; Rak JW; Coomber BL Cancer Res; 2005 Sep; 65(18):8134-41. PubMed ID: 16166287 [TBL] [Abstract][Full Text] [Related]
27. Two mismatch repair gene mutations found in a colon cancer patient--which one is pathogenic? Kariola R; Otway R; Lönnqvist KE; Raevaara TE; Macrae F; Vos YJ; Kohonen-Corish M; Hofstra RM; Nyström-Lahti M Hum Genet; 2003 Feb; 112(2):105-9. PubMed ID: 12522549 [TBL] [Abstract][Full Text] [Related]
28. Mouse mismatch repair gene Msh2 is not essential for transcription-coupled repair of UV-induced cyclobutane pyrimidine dimers. Sonneveld E; Vrieling H; Mullenders LH; van Hoffen A Oncogene; 2001 Jan; 20(4):538-41. PubMed ID: 11313985 [TBL] [Abstract][Full Text] [Related]
29. Enhanced intestinal adenomatous polyp formation in Pms2-/-;Min mice. Baker SM; Harris AC; Tsao JL; Flath TJ; Bronner CE; Gordon M; Shibata D; Liskay RM Cancer Res; 1998 Mar; 58(6):1087-9. PubMed ID: 9515784 [TBL] [Abstract][Full Text] [Related]
30. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Fishel R; Lescoe MK; Rao MR; Copeland NG; Jenkins NA; Garber J; Kane M; Kolodner R Cell; 1994 Apr; 77(1):1 p following 166. PubMed ID: 8156592 [No Abstract] [Full Text] [Related]
31. Role of Red Meat and Resistant Starch in Promutagenic Adduct Formation, MGMT Repair, Thymic Lymphoma and Intestinal Tumourigenesis in Msh2 -Deficient Mice. Winter JM; Hu Y; Young GP; Kohonen-Corish MR; Le Leu RK J Nutrigenet Nutrigenomics; 2014; 7(4-6):299-313. PubMed ID: 26022687 [TBL] [Abstract][Full Text] [Related]
32. Microsatellite instability: the mutator that mutates the other mutator. Perucho M Nat Med; 1996 Jun; 2(6):630-1. PubMed ID: 8640546 [No Abstract] [Full Text] [Related]
33. Mutation in the mismatch repair gene Msh6 causes cancer susceptibility. Edelmann W; Yang K; Umar A; Heyer J; Lau K; Fan K; Liedtke W; Cohen PE; Kane MF; Lipford JR; Yu N; Crouse GF; Pollard JW; Kunkel T; Lipkin M; Kolodner R; Kucherlapati R Cell; 1997 Nov; 91(4):467-77. PubMed ID: 9390556 [TBL] [Abstract][Full Text] [Related]
34. Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer. de Wind N; Dekker M; Berns A; Radman M; te Riele H Cell; 1995 Jul; 82(2):321-30. PubMed ID: 7628020 [TBL] [Abstract][Full Text] [Related]
35. [Hereditary intestinal tumor observed after irradiation of multiple generations of a male germinal line of C57BL/6 mice]. Mewissen DJ; Ugarte AS; Rust JH C R Seances Soc Biol Fil; 1984; 178(2):230-5. PubMed ID: 6235902 [TBL] [Abstract][Full Text] [Related]
37. RhoA downregulation in the murine intestinal epithelium results in chronic Wnt activation and increased tumorigenesis. Dopeso H; Rodrigues P; Cartón-García F; Macaya I; Bilic J; Anguita E; Jing L; Brotons B; Vivancos N; Beà L; Sánchez-Martín M; Landolfi S; Hernandez-Losa J; Ramon Y Cajal S; Nieto R; Vicario M; Farre R; Schwartz S; van Ijzendoorn SCD; Kobayashi K; Martinez-Barriocanal Á; Arango D iScience; 2024 Apr; 27(4):109400. PubMed ID: 38523777 [TBL] [Abstract][Full Text] [Related]
38. Consequences of the Hsp110DE9 mutation in tumorigenesis and the 5-fluorouracil-based chemotherapy response in Msh2-deficient mice. Noel K; Bokhari A'; Bertrand R; Renaud F; Bourgoin P; Cohen R; Svrcek M; Joly AC; Duval A; Collura A Cell Mol Life Sci; 2022 Jun; 79(6):332. PubMed ID: 35648235 [TBL] [Abstract][Full Text] [Related]
39. Of the many cellular responses activated by TP53, which ones are critical for tumour suppression? Thomas AF; Kelly GL; Strasser A Cell Death Differ; 2022 May; 29(5):961-971. PubMed ID: 35396345 [TBL] [Abstract][Full Text] [Related]
40. Human Colorectal Cancer from the Perspective of Mouse Models. Stastna M; Janeckova L; Hrckulak D; Kriz V; Korinek V Genes (Basel); 2019 Oct; 10(10):. PubMed ID: 31614493 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]